Can be ordered as part of the acute hepatitis panel, which includes HAV IgM, HBV core antibody IgM, HBV surface antigen, and HCV antibody to determine if patient has acute HBV infection; refer to Hepatitis Panel, Acute with Reflex to HBsAg Confirmation and Reflex to HCV by Quantitative NAAT (3002989).
Qualitative Chemiluminescent Immunoassay
Within 24 hours
New York DOH Approval Status
Serum separator tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Also acceptable: K2EDTA plasma.
Heparinized plasma. Specimens containing particulate material. Heat-inactivated, severely hemolyzed, or lipemic specimens.
After separation from cells: Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)
This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular Tissue-Based Products (HCT/P).
|Component Test Code*||Component Chart Name||LOINC|
|0020092||Hepatitis B Core Antibody, IgM||24113-3|
- Anti Core IgM Antibody
- Anti-Hepatitis Bc
- Core Antibody IgM
- HBV Core IgM
- Hep B Core Ab IgM
- Hep Bc Ab IgM
- IgM Antibody to Hepatitis Bc